HARROW, INC. — Director's Dealing 2018

Feb 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2018-02-01

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	M	30000	$1.83	Acquired	30000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Restricted Stock Unit	$0	M	30000	Disposed		Common Stock (30000)	Direct

Footnotes

F1: On February 1, 2018, restricted stock units ("RSUs") granted to Mr. Saharek on February 1, 2015 vested, and 30,000 shares of common stock were issued to him. Payroll withholding taxes related to the vested RSUs and share issuance were paid by Mr. Saharek.